• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞自主的 IL6ST 激活通过 STAT3/ARF/p53 驱动的衰老抑制前列腺癌的发展,并赋予免疫活性的肿瘤微环境。

Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment.

机构信息

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Biochemical Institute, University of Kiel, Kiel, Germany.

出版信息

Mol Cancer. 2024 Oct 31;23(1):245. doi: 10.1186/s12943-024-02114-8.

DOI:10.1186/s12943-024-02114-8
PMID:39482716
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11526557/
Abstract

BACKGROUND

Prostate cancer ranks as the second most frequently diagnosed cancer in men worldwide. Recent research highlights the crucial roles IL6ST-mediated signaling pathways play in the development and progression of various cancers, particularly through hyperactivated STAT3 signaling. However, the molecular programs mediated by IL6ST/STAT3 in prostate cancer are poorly understood.

METHODS

To investigate the role of IL6ST signaling, we constitutively activated IL6ST signaling in the prostate epithelium of a Pten-deficient prostate cancer mouse model in vivo and examined IL6ST expression in large cohorts of prostate cancer patients. We complemented these data with in-depth transcriptomic and multiplex histopathological analyses.

RESULTS

Genetic cell-autonomous activation of the IL6ST receptor in prostate epithelial cells triggers active STAT3 signaling and significantly reduces tumor growth in vivo. Mechanistically, genetic activation of IL6ST signaling mediates senescence via the STAT3/ARF/p53 axis and recruitment of cytotoxic T-cells, ultimately impeding tumor progression. In prostate cancer patients, high IL6ST mRNA expression levels correlate with better recurrence-free survival, increased senescence signals and a transition from an immune-cold to an immune-hot tumor.

CONCLUSIONS

Our findings demonstrate a context-dependent role of IL6ST/STAT3 in carcinogenesis and a tumor-suppressive function in prostate cancer development by inducing senescence and immune cell attraction. We challenge the prevailing concept of blocking IL6ST/STAT3 signaling as a functional prostate cancer treatment and instead propose cell-autonomous IL6ST activation as a novel therapeutic strategy.

摘要

背景

前列腺癌是全球男性中第二大常见的癌症。最近的研究强调了 IL6ST 介导的信号通路在各种癌症的发展和进展中所起的关键作用,特别是通过过度激活 STAT3 信号。然而,IL6ST/STAT3 在前列腺癌中介导的分子程序还知之甚少。

方法

为了研究 IL6ST 信号的作用,我们在体内 Pten 缺陷的前列腺癌小鼠模型中使前列腺上皮细胞中的 IL6ST 信号持续激活,并在大量前列腺癌患者中检查了 IL6ST 的表达。我们用深入的转录组学和多重组织病理学分析来补充这些数据。

结果

在前列腺上皮细胞中遗传细胞自主激活 IL6ST 受体,触发活跃的 STAT3 信号,并显著减少体内肿瘤的生长。从机制上讲,IL6ST 信号的遗传激活通过 STAT3/ARF/p53 轴和募集细胞毒性 T 细胞来介导衰老,最终阻碍肿瘤的进展。在前列腺癌患者中,高 IL6ST mRNA 表达水平与无复发生存率增加、衰老信号增加以及从免疫冷肿瘤向免疫热肿瘤的转变相关。

结论

我们的研究结果表明,IL6ST/STAT3 在致癌作用中有一个依赖于背景的作用,并通过诱导衰老和吸引免疫细胞,在前列腺癌的发展中发挥肿瘤抑制作用。我们挑战了阻断 IL6ST/STAT3 信号作为功能性前列腺癌治疗的既定概念,而是提出了细胞自主的 IL6ST 激活作为一种新的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/925cee3029bd/12943_2024_2114_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/3fe374fd370b/12943_2024_2114_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/7318e7520ad8/12943_2024_2114_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/de377a8deda7/12943_2024_2114_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/139106658fc6/12943_2024_2114_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/9618b12fb03d/12943_2024_2114_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/16658e01a607/12943_2024_2114_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/925cee3029bd/12943_2024_2114_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/3fe374fd370b/12943_2024_2114_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/7318e7520ad8/12943_2024_2114_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/de377a8deda7/12943_2024_2114_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/139106658fc6/12943_2024_2114_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/9618b12fb03d/12943_2024_2114_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/16658e01a607/12943_2024_2114_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f213/11526557/925cee3029bd/12943_2024_2114_Fig7_HTML.jpg

相似文献

1
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment.细胞自主的 IL6ST 激活通过 STAT3/ARF/p53 驱动的衰老抑制前列腺癌的发展,并赋予免疫活性的肿瘤微环境。
Mol Cancer. 2024 Oct 31;23(1):245. doi: 10.1186/s12943-024-02114-8.
2
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.JUN 介导衰老相关分泌表型和免疫细胞募集,以防止前列腺癌进展。
Mol Cancer. 2024 May 29;23(1):114. doi: 10.1186/s12943-024-02022-x.
3
STAT3 regulated ARF expression suppresses prostate cancer metastasis.信号转导和转录激活因子3(STAT3)调控的ARF表达抑制前列腺癌转移。
Nat Commun. 2015 Jul 22;6:7736. doi: 10.1038/ncomms8736.
4
Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.肿瘤发生过程中p19(Arf)缺失导致的不依赖p53的不同结果
Sci Signal. 2009 Aug 18;2(84):ra44. doi: 10.1126/scisignal.2000053.
5
IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer.白细胞介素-6/信号转导与转录激活因子3/衰老抑制因子:前列腺癌衰老、进展和转移的守护者
Swiss Med Wkly. 2015 Dec 21;145:w14215. doi: 10.4414/smw.2015.14215. eCollection 2015.
6
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.Skp2 靶向抑制 Arf-p53 非依赖性细胞衰老从而抑制肿瘤发生。
Nature. 2010 Mar 18;464(7287):374-9. doi: 10.1038/nature08815.
7
Growth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinoma.生长停滞和 DNA 损伤 45G 下调导致肝细胞癌中 Janus 激酶/信号转导和转录激活因子 3 的激活和细胞衰老逃逸。
Hepatology. 2014 Jan;59(1):178-89. doi: 10.1002/hep.26628. Epub 2013 Nov 18.
8
A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.一种天然雄激素受体拮抗剂可诱导前列腺癌细胞发生细胞衰老。
Mol Endocrinol. 2014 Nov;28(11):1831-40. doi: 10.1210/me.2014-1170. Epub 2014 Sep 9.
9
MiR362-3p Alleviates Osteosarcoma by Regulating the IL6ST/JAK2/STAT3 Pathway and .miR362-3p 通过调控 IL6ST/JAK2/STAT3 通路缓解骨肉瘤 及其相关机制的研究
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241261616. doi: 10.1177/15330338241261616.
10
Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.五没食子酰基-β-D-葡萄糖在体外可诱导前列腺癌细胞中的p53表达并抑制STAT3,在体内可抑制前列腺异种移植肿瘤的生长。
Mol Cancer Ther. 2008 Sep;7(9):2681-91. doi: 10.1158/1535-7163.MCT-08-0456.

引用本文的文献

1
Targeting Senescence in Oncology: An Emerging Therapeutic Avenue for Cancer.肿瘤学中的衰老靶向治疗:癌症治疗的新兴途径
Curr Oncol. 2025 Aug 18;32(8):467. doi: 10.3390/curroncol32080467.
2
Construction of Gene Regulatory Networks Based on Spatial Multi-Omics Data and Application in Tumor-Boundary Analysis.基于空间多组学数据的基因调控网络构建及其在肿瘤边界分析中的应用
Genes (Basel). 2025 Jul 13;16(7):821. doi: 10.3390/genes16070821.
3
MUW researcher of the month.本月穆尔西亚大学研究员。

本文引用的文献

1
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.JUN 介导衰老相关分泌表型和免疫细胞募集,以防止前列腺癌进展。
Mol Cancer. 2024 May 29;23(1):114. doi: 10.1186/s12943-024-02022-x.
2
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.STAT3/LKB1 通过调控 mTORC1/CREB 通路控制转移性前列腺癌。
Mol Cancer. 2023 Aug 12;22(1):133. doi: 10.1186/s12943-023-01825-8.
3
Synthetic cytokine circuits that drive T cells into immune-excluded tumors.
Wien Klin Wochenschr. 2025 Jul;137(13-14):457-458. doi: 10.1007/s00508-025-02572-0.
4
FOS-driven inflammatory CAFs promote colorectal cancer liver metastasis via the SFRP1-FGFR2-HIF1 axis.FOS驱动的炎性癌相关成纤维细胞通过SFRP1-FGFR2-HIF1轴促进结直肠癌肝转移。
Theranostics. 2025 Mar 21;15(10):4593-4613. doi: 10.7150/thno.111625. eCollection 2025.
5
p53: A player in the tumor microenvironment.p53:肿瘤微环境中的一个参与者。
Oncol Res. 2025 Mar 19;33(4):795-810. doi: 10.32604/or.2025.057317. eCollection 2025.
6
STAT3/TGFBI signaling promotes the temozolomide resistance of glioblastoma through upregulating glycolysis by inducing cellular senescence.信号转导与转录激活因子3/转化生长因子β诱导蛋白(STAT3/TGFBI)信号通路通过诱导细胞衰老上调糖酵解,从而促进胶质母细胞瘤对替莫唑胺的耐药性。
Cancer Cell Int. 2025 Apr 3;25(1):127. doi: 10.1186/s12935-025-03770-6.
7
YEATS2 promotes malignant phenotypes of esophageal squamous cell carcinoma via H3K27ac activated-IL6ST.YEATS2通过H3K27ac激活的IL6ST促进食管鳞状细胞癌的恶性表型。
Front Cell Dev Biol. 2025 Feb 18;13:1497290. doi: 10.3389/fcell.2025.1497290. eCollection 2025.
合成细胞因子电路将 T 细胞驱入免疫排斥肿瘤中。
Science. 2022 Dec 16;378(6625):eaba1624. doi: 10.1126/science.aba1624.
4
Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.用于检测临床显著前列腺癌的分子生物标志物:一项系统综述和荟萃分析。
Eur Urol Open Sci. 2022 Nov 10;46:105-127. doi: 10.1016/j.euros.2022.10.017. eCollection 2022 Dec.
5
STAT3 and Its Pathways' Dysregulation-Underestimated Role in Urological Tumors.STAT3 及其信号通路失调在泌尿系统肿瘤中的被低估作用。
Cells. 2022 Sep 27;11(19):3024. doi: 10.3390/cells11193024.
6
Targeting senescence as an anticancer therapy.靶向衰老作为一种抗癌疗法。
Mol Oncol. 2022 Nov;16(21):3855-3880. doi: 10.1002/1878-0261.13312. Epub 2022 Sep 23.
7
Senescence and cancer - role and therapeutic opportunities.衰老与癌症——作用与治疗机遇。
Nat Rev Clin Oncol. 2022 Oct;19(10):619-636. doi: 10.1038/s41571-022-00668-4. Epub 2022 Aug 31.
8
Cellular senescence: the good, the bad and the unknown.细胞衰老:好的、坏的和未知的。
Nat Rev Nephrol. 2022 Oct;18(10):611-627. doi: 10.1038/s41581-022-00601-z. Epub 2022 Aug 3.
9
Targeting the Tumor Microenvironment: A Close Up of Tumor-Associated Macrophages and Neutrophils.靶向肿瘤微环境:肿瘤相关巨噬细胞和中性粒细胞特写
Front Oncol. 2022 May 19;12:871513. doi: 10.3389/fonc.2022.871513. eCollection 2022.
10
PTEN-PI3K pathway alterations in advanced prostate cancer and clinical implications.晚期前列腺癌中 PTEN-PI3K 通路改变及其临床意义。
Prostate. 2022 Aug;82 Suppl 1:S60-S72. doi: 10.1002/pros.24372.